Introduction
Endometrial cancer is one of the most common gynecological malignancies worldwide. Surgery is the preferred initial treatment and most women with early-stage, low-risk disease will do well without adjuvant radiotherapy. However, both intermediate-risk and high-risk patients are at risk for localregional relapse and therefore adjuvant radiotherapy, such as pelvic radiation, vaginal brachytherapy, and whole-abdomen radiation, is essential for local control (1) . Johnson and colleagues reported that adjuvant external-beam pelvic radiotherapy offered a significant disease-free survival advantage for high-risk endometrial cancer (2) .
Although endometrial carcinoma was relatively radiosensitive as a group, great variance in the inherent radiation sensitivity between individual cell lines derived from endometrial carcinomas has been found (3) . Moreover, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished susceptibility of the irradiated cells to undergo apoptosis. Preliminary studies using microarray technology have generated a list of candidate biomarker genes that provide discrimination between radiosensitive and radioresistant cells in different types of malignant tumors (4-7), but none for endometrial cancer. This lack of data prompted us to carry out expression profiling on endometrial cancer cells with different radiosensitivity. The purpose of this study was to determine the patterns of gene expression responsible for radiosensitivity of endometrial cancer and search for potential target genes for radiotherapy.
penicillin/streptomycin. The cultures were incubated at 37˚C in a humidified 5% CO 2 incubator.
Clonogenic cell survival assay. Survival following radiation exposure was defined as the ability of the cells to maintain clonogenic capacity and form colonies. Cells were cultured until 70-80% confluent, and then exposed to X-rays from a VARIAN clinical 2100C/D linear accelerator (Palo Alto, CA) at a dose rate of 2.0 Gy/min. Subsequently, cells were trypsinized and transferred to 6-well plates at 1x10 3 cells/ well in complete culture medium. After 10 days of incubation, colonies were fixed and stained in 2% crystal violet in absolute ethanol. Colonies consisting of ≥50 cells were scored, and five replicate dishes were counted for each treatment. The plating efficiency was calculated for each well by dividing the number of colonies by the original number of cells plated. The surviving fraction was normalized to control cell plating efficiency by dividing the plating efficiency of treated cells by that of control cells.
Cell cycle analysis. After exposure to 6 Gy radiation, cells were harvested by trypsinization (Invitrogen), washed with PBS, fixed, and stored at 4˚C before DNA analysis. After removal of ethanol, cells were washed again in PBS and stained for 30 min at room temperature with 1 ml DNA fluorochrome solution containing 200 μg propidium iodide (Sigma, St. Louis, MO), 0.1% Triton X-100 (Sigma), and 2 mg DNase-free ribonuclease A (Sigma). Resulting DNA distributions were analyzed using a FACScan flow cytometer (Becton-Dickinson Co., San Jose, CA) for the proportion of cells in G 0 /G 1 , S and G 2 /M phases of the cell cycle.
Assessment of apoptosis.
The Annexin V-FITC kit (BD Biosciences, San Diego, CA) was used to detect early apoptotic activity of cells exposed to 6 Gy radiation according to the manufacturer's instructions, with slight modifications. The apoptotic percentage of 10,000 cells was determined, after which all the experiments reported in this study were performed 3 times. The data were analyzed using WinMDI 2.8 software (Scripps Institute, La Jolla, CA) for calculation of percentage cells with apoptosis per group.
RNA extraction and microarray analysis. Total RNA was harvested from cells before and 1 h after 6 Gy radiation exposure using TRIzol (Invitrogen), concentrated using isopropyl alcohol precipitation, and further purified using RNeasy Mini kit (Qiagen, Valencia, CA) according to the manufacturer's protocols. The quantity and quality of the purified RNA were assessed by OD260 and OD280 measurements on a spectrophotometer and the integrity was determined by formaldehyde denatured gel electrophoresis.
Microarray experiments were performed using a 22K Human Genome Oligonucleotide Microarray Kit containing 21,329 well-characterized Homo sapiens genes (CapitalBio Corp., Beijing, P.R. China) following the manufacturer's instructions. The cDNA probes were synthesized by reverse Table I. Sequences of primers used for qRT-PCR.  -----------------------------------------------------------------------------------------------------Gene symbol  Gene bank ID  Primer sequence  Annealing temperature (˚C)  -----------------------------------------------------------------------------------------------------ADM  NM_001124  F: 5'-TTCAGCAGGGTATCGGAGC-3'  57  R: 5'-CCGACTGTTCAATGCTGCC-3'  HMOX1  NM_002133  F: 5'-CGCCTTCCTGCTCAACATT-3'  60  R: 5'-TGTGTTCCTCTGTCAGCATCAC-3'  LOX  NM_002317  F: 5'-CTGCCTGGCCAGTTCAGCATAT-3'  58  R: 5'-TCCACTGGCAGTCTATGTCTGC-3'  TNC  NM_002160  F: 5'-GTTTGGAGACCGCAGAGAAGAA-3'  58  R: 5'-TGTCCCCATATCTGCCCATCA-3'  MMP-10 NM_002425
transcription and purified as previously described (8) . Cy5 and Cy3-dCTP-labeled DNA were hybridized to the microarray according to the manufacturer's recommendations. Arrays were scanned with LuxScan 10K/A double channel laser scanner (CapitalBio Corp.). For each test and control sample, two hybridizations were performed by using a reverse fluorescence strategy. Differential expression was determined using the combined basis of t-test with P<0.05 and fold changes (either up or down) of ≥2-fold. Only genes whose alteration tendency was consistent (both above 2-fold) in both microarrays were selected as differentially expressed genes. All differentially expressed genes were analyzed using Molecular Annotation System 5.0 (MAS 5.0, www. capitalbio.com) which integrates three pathway resources-KEGG, BioCarta and GenMAPP.
Quantitative real-time polymerase chain reaction (PCR) validation. Real-time PCR was performed on an ABI Prism 7000 Sequence Detection System using SYBR-Green RT-PCR Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocols. The primers used for real-time PCR are shown in Table I . The protocol of real-time PCR was as follows: initiation with a 10-min denaturation at 95˚C, followed by 40 cycles of amplification at 95˚C (10 sec) for denaturation, 55˚C (10 sec) for annealing, and 72˚C for extension. The real-time PCR amplification product was analyzed by melting curve analysis and 1.2% agarose gel electrophoresis, respectively. and transferred to a nitrocellulose membrane. After blocking with 5% TBST-milk, membranes were incubated with mouse monoclonal anti-ADM (1:2 500), anti-LOX, anti-MMP10, rabbit polyclonal anti-IL23A (Santa Cruz Biotechnology, Santa Cruz, CA), anti-MYC and anti-HAS2 (Stressgen Biotechnologies) and anti-ß-actin (Sigma) antibodies overnight at 4˚C. Then the membranes were incubated with horseradish peroxidase (HP)-conjugated anti-rabbit or anti-mouse IgG antibody, respectively (Santa Cruz Biotechnology). Membranes were incubated in SuperSignal ® West Pico Chemiluminescent Substrate (Pierce), exposed to CL-Xposure Film™ (Pierce) and developed using an All-Pro 100 Plus automated X-ray film processor (All-Pro Imaging Corporation, Hicksville, NY). The resultant bands were quantified using AlphaEaseFC™ software (AlphaInnotech, San Leandro, CA).
Statistical analysis. Data were analyzed with SPSS 10.0 statistical software (SPSS, Chicago, IL, USA). Comparisons of survival fractions in the clonogenic assays among the various treatment groups were analyzed by two-tailed unpaired Student's t-test. Comparisons between means in the Western blot were analyzed by Student's t-test. A p-value <0.05 was considered statistically significant.
Results
Clonogenic cell survival assay. Cells from the ISK, HHUA, RL95-2, and KLE cell lines were irradiated, and survival curves were determined from the postirradiated cells by Table II . Genes that were expressed at least 3-fold higher in ISK/ISK-R. 
colony formation assay. Fig. 1 depicts clonogenic survival curves for the four cell lines exposed by X-ray radiation. Cell line KLE was classified as radiation-sensitive, and cell lines ISK were classified as relatively radiation resistant.
Cell cycle arrest after irradiation. The capacity of radiation to inhibit cell cycle progression was evaluated via flow cytometry. As shown in Fig. 2 , radiation caused a significant decrease in S-phase cell population (46.5% vs. 36.7% in ISK and 21.9% vs. 6.9% in KLE cells, respectively), accompanied by a concomitant accumulation in the G 2 /M-phase cell population (11.3% vs. 43.9% in ISK and 37% vs. 61.4% in KLE), 24 h after ionizing radiation (IR) treatment. The cell cycle distribution showed higher fractions of G 2 /M phase cells in KLE cells before, 12 and 24 h after radiation treatment compared with ISK (P<0.05). However, although test results were reproducible and consistent, the difference of decreased S-phase fraction between two cell lines did not yield statistical significance (P>0.05).
Effects on apoptosis rate. To investigate the effects of irradiation on the induction of apoptosis in ISK and KLE cells, Annexin V-FITC/PI staining and flow cytometric measurement were used to quantify the percentages of apoptosis in the total cell population. As shown in Fig. 3 , after irradiation for 24 h, the percentages of early apoptosis cells (Annexin V+/PI-) increased from 1.58 to 9.25% in KLE cells and 2.88 to 4.60% in ISK cells, respectively. Significant elevation in the percentage of apoptosis cells were observed in KLE cells than ISK cells (P<0.05). These results suggest that radiation is more effective in inducing early apoptosis in KLE cells than in ISK cells.
Gene expression profiling of ISK and KLE cells in response to X-ray radiation.
Microarray analysis revealed distinct gene expression patterns of temporal gene response to X-ray radiation in the two cell lines. There were 227 (70 upregulated and 157 down-regulated) and 354 (121 upregulated and 233 down-regulated) differentially expressed genes in ISK and KLE cells, respectively. Tables II and III show genes that were expressed at least 3-fold higher in ISK/ISK-R and KLE/KLE-R, respectively) We also categorized the differently expressed genes by pathway analysis. The temporal expression genes were associated with cell cycle, DNA damage and repair, MAPK signaling pathway, cell adhesion, metabolism and so on. The log 2 transformed data of the genes regulated by IR in ISK and KLE cells are shown as hierarchical cluster diagrams (Fig. 4) . Comparison of gene expression profiles of ISK and KLE in response to radiation. When the gene expression profiles of ISK and KLE cells in response to radiation were compared, it was found that 66 genes were commonly regulated in a similar manner in both groups (data not shown). In ISK 161 genes and in KLE cells 288 genes were exclusively regulated by radiation. However, because more than half of these genes have small differences in expression level between groups, the difference might be caused by data fluctuation. Therefore, genes showing differences more than double the median expression value between the two groups (μX ISK /μX KLE ≤0.5 or ≥2.0, where μX ISK and μX KLE indicate median X values for the ISK or KLE group, respectively; and X= the Cy5/Cy3 signal intensity ratio for each gene and for each sample) were defined as radiosensitivity (or radioresistance)-related genes. We selected a total of 53 genes as being differently expressed between ISK and KLE groups. Of those 53 genes, 24 revealed increased expression, and 29 showed decreased expression, in ISK group compared with KLE group (Table IV) . To investigate the biological functions involved in the discriminating genes, we performed Gene Ontology category analysis. According to the gene function, categories of apoptosis, growth factor, and cell adhesion molecule activity, showed significantly higher proportion among selected 53 genes.
The list of genes up-regulated in ISK cells included a member of growth factor (NELL2, INHBB), proliferation regulator (HOXB9 GADD45B), as well as genes related to cell communication (TYRO3) or extracellular matrix (LOX). Genes that are considered to be associated with repair of breaks in double-stranded DNA, including DNA repair protein RAD51 homolog 3 (RAD51C) and Rad3 related protein (ATR) were also elevated in the ISK group. Genes up-regulated in KLE cells include mitogen-activated protein kinase kinase 1 (MAP2K1), regulator of G-protein signaling 2 (RGS2), and RAB2 (a member of the RAS oncogene family). In addition, among six genes related to apoptosis, P8 protein (P8) and programmed cell death 5 (PDCD5), which induce apoptosis, showed significantly higher expression in KLE cells. On the other hand, four genes, Cysteine-rich 61 (CYR61), Apolipoprotein E (APOE), Mdm2 p53 binding protein homolog (MDM2) and Heat shock 70 kDa protein 5 (HSPA5), which inhibit apoptosis, showed higher expression in ISK cells.
Validation of microarray results by quantitative RT-PCR.
To show the reproducibility of the microarray analysis, 10 genes were selected at random, spanning a range of foldchanges (3.4-22.9; Fig. 5 ). The microarray analysis identified ADM (6.9-fold), HMOX1 (6.0-fold), LOX (4.9-fold), TNC (3.7-fold), and MMP10 (3.5-fold) as being significantly Table III . Genes that were expressed at least 3-fold higher in KLE/KLE-R. Table IV . Candidate genes that were detected by oligonucleotide microarray analysis between ISK and KLE cells after radiation treatment. ----------------------------------------------------------------------------------------------------- increased in ISK group, IL23A (22.9-fold), MYC (4.2-fold), PRSS22 (7.4-fold), GS2 (6.8-fold), and HAS2 (5.4-fold) in KLE group, and these changes were validated by real-time RT-PCR. Fig. 5 shows relative gene expression compared with control cells. These data provide important confirmation of the gene expression alterations identified by the microarray analysis.
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Western blot analysis. To examine whether the gene expression alterations identified by the microarray analysis and qRT-PCR also occur at the protein level, we performed Western blot analysis for 6 proteins. Increased expression of ADM, LOX, and MMP10 protein in radiation treated ISK cells and elevated expression of IL23A, MYC, and HAS2 in radiation treated KLE were confirmed at the protein level (Fig. 6 ).
Discussion
Microarray analysis is a powerful tool for obtaining comprehensive information on expression of thousands of genes in cancer cells. There have been a few studies aimed at predicting response to radiotherapy using gene expression profiling in the treatment of esophageal, rectal, nasopharyngeal cancer and neuroblastoma (4, 6, 10, 11) . Identification of the genes differentially expressed between radiosensitive and radioresistant cancers may provide new insights into the mechanisms underlying clinical radioresistance and improve the efficacy of radiotherapy (11) . Although the role of radiotherapy is essential in the treatment of endometrial carcinoma, present knowledge of the radiation sensitivity of this kind of malignacy is mostly empirical and based on clinical trials. To elucidate the further molecular events involved in radiosensitivity of endometrial cancer, we examined global expression patterns of two cell lines with different radiosensitivities.
In the present study, we found genes that showed different expression patterns between two cell lines of distinct radiosensitivities and, therefore, were likely to reflect differences in the response of endometrial cancer cells to radiotherapy. Many genes associated with DNA-repair, apoptosis, growth factor, signal transduction, cell cycle and cell adhesion were obviously differently expressed between the two cell lines, and similar results had been reported in certain types of malignant cells by previous studies (12, 13) . This list of genes may be useful when attempting to predict and sensitize the radioresistant endometrial cancer cells. In radioresistant ISK cells, we found elevated expression of Heme oxygenase-1 (HMOX1, HO-1) after X-ray exposure. HMOX1 is believed to represent a key enzyme for the protection of cells against 'stress'. Elevated HMOX expression and activity was found in different types of human cancers such as human glioblastoma (14) and pancreatic cancer (15) . HMOX1 was also found to accelerate cancer growth and contributes to cellular resistance against chemotherapy and radiotherapy (15,16). Berberat and colleagues found that targeted knockdown of HMOX1 expression led to pronounced growth inhibition of the pancreatic cancer cells and made tumor cells significantly more sensitive to radiotherapy and chemotherapy. It is generally known that the destructive mechanisms of radiotherapy on cancer cells are mainly based on the generation of oxidative stress and the occurrance of radioresistance is a general clinical problem in cancer treatment. As a stress response gene, pronounced up-regulation of HMOX1 after first time treatment can lead to the resistance of further therapy. Therefore, specific inhibition of HMOX1 expression may be used as sensitizer to radiotherapy. No data on the expression of this gene in endometrial cancer have been reported until now and the molecular basis of these effects on cancers is not yet clear.
Another important factor in destructive mechanism of radiotherapy on cancer cells is the induction of apoptosis. We observed significant elevation in the percentage of apoptosis cells in KLE cells than ISK cells in response to irradiation. This may suggest that radiation is more effective in inducing early apoptosis in KLE cells. Among differently expressed genes related to apoptosis, Mdm2 p53 binding protein homolog (MDM2), Heat shock 70 kDa protein 5 (HSPA5), Heat shock 70 kDa protein 1A (HSP70-1A), Cysteine-rich 61 (CYR61), and Apolipoprotein E (APOE), which inhibit apoptosis, showed higher expression in ISK cells.
MDM2 is a target gene of the transcription factor tumor protein p53. Overexpression of this gene can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. Studies indicate that MDM2 has a critical role in regulating p53 response to DNA-damaging therapies (17) . Inhibition of MDM2 has been shown to sensitize thyroid and lung cancer to ionizing radiation (18, 19) . Cao and colleagues suggested that MDM2 inhibition sensitized the H460 lung cancer model to irradiation via induction of apoptosis and senescence as well as by enhancing the antivascular effects of radiation (19) . However, the signals that regulate its expression and its role in radiosensitivity of endometrial cancer remain unknown.
HSPA5 and HSP70-1A are members of the heat-shock protein-70 (HSP70) family. They are involved in the folding and assembly of proteins in the endoplasmic reticulum and may play a key role in monitoring protein transport through the cell. Heat-shock proteins (Hsps) synthesis can be increased by cellular damage induced by radiation. Inducible Hsp70 has been suggested to have multiple roles in cytoprotection against apoptosis. Accordingly, high levels of Hsp70 prevent stress-induced apoptosis. Brondani and colleagues reported that the content of Hsp70 is associated with glioblastoma cell radioresistance (20) . The overexpression of Hsp70 or/ and Hsp27 also enhanced radioresistance of mouse embryo fibroblasts (21) . In the present study, we found that HSPA5 and HSP70-1A contents increased by 2.8-fold and 2.2-fold in the ISK cells after radiation, respectively, but did not significantly change in the KLE cells. Thus, our results suggest that Hsp70 protection against radiation-induced apoptosis might underlie radioresistance of endometrial cancer, and further investigation should be conduct in the future.
The cell cycle of tumor cells often changes after irradiation. Tumor cells are known to be most sensitive to radiation-induced cell death when synchronized in the G 2 /M phase of the cell cycle, as the DNA is more vulnerable to radiation-induced damage during mitosis. We observed that more KLE cells arrested in G 2 /M-phase than ISK cells in response to irradiation. This may partly explain why KLE cells are more radiosensitive than ISK in cell cycle kinetics. GADD45B (growth arrest and DNA-damage-inducible, beta) is a key member of nuclear proteins inducible by DNAdamaging stresses and play an active role in cell cycle adjustment that affects cell survival (22) . GADD45 proteins interact with the complex of Cdk1 and CyclinB1, both of which are required for IR-induced cell cycle regulation and radioresistance (23) . It has been long observed that IRinduced GADD45B expression is linked to p53 pathways. Recently, Wang and colleagues demonstrated that NK-κB, ERK and GADD45ß are co-activated by ionizing radiation (IR) and coordinate in a loop-like signaling network to defend cells against the cytotoxicity induced by ionizing radiation and increase cell survival (24) . Data from our study show that GADD45B was elevated in ISK cells after IR exposure. These findings suggest that GADD45B inhibition may also be used as a new option in endometrial cancer treatment.
In summary, the gene expression profiles derived in the current study define unique alterations in gene expression of endometrial cancer cells with different radiosensitivities. Our finding should be useful not only as an aid to find predicting radiosensitivity-related genes in endometrial cancer, but also as a means to find potential targets to sensitize radioresistant tumor cells and improve radiocurability. In future studies, the novel genes identified have to be evaluated in cancer models both in vitro and in vivo.
